1h Free Analyst Time
This publisher has monitored the preclinical animal telemetry market and according to this report it is poised to grow by $14.63 mn during 2021-2025, progressing at a CAGR of 4.91% during the forecast period. The report the preclinical animal telemetry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing growth in preclinical research and testing and growing demand for lowering the attrition rate in translational research.
The preclinical animal telemetry market analysis includes End-User and type segments and geographic landscape.
The preclinical animal telemetry market is segmented as below:
By End-User
- industrial laboratories and CROs
By Type
- small animal telemetry
- large animal telemetry
By Geographical Landscape
- North America
- Europe
- Asia
This study identifies the increase in product launches as one of the prime reasons driving the preclinical animal telemetry market growth during the next few years.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The report preclinical animal telemetry market covers the following areas:
- Preclinical animal telemetry market sizing
- Preclinical animal telemetry market forecast
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical animal telemetry market vendors that include ADInstruments Pty Ltd., BIOPAC Systems Inc., Cambridge NeuroTech, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Indus Instruments, Instem Group, Star-Oddi, and TSE Systems GmbH. Also, the preclinical animal telemetry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Five Forces Analysis
Customer landscape
Vendor Landscape
Executive Summary
The publisher has identified the following companies as the key players in the global preclinical animal telemetry market: ADInstruments Pty Ltd., BIOPAC Systems Inc., Cambridge NeuroTech, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Indus Instruments, Instem Group, Star-Oddi, and TSE Systems GmbH.Commenting on the report, an analyst from the publisher said 'The latest trend gaining momentum in the market is increase in product launches.'
According to the report, one of the major drivers for this market is the increasing growth in preclinical research and testing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- ADInstruments Pty Ltd.
- BIOPAC Systems Inc.
- Cambridge NeuroTech
- emka TECHNOLOGIES
- ETISENSE SAS
- Harvard Bioscience Inc.
- Indus Instruments
- Instem Group
- Star-Oddi
- TSE Systems GmbH